TrialThe British journal of ophthalmology2026

Efficacy and safety of anti-VEGF monoclonal antibody 601 for macular oedema in retinal vein occlusion: two phase IIa randomised clinical trials.

Shuo Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.